tak-951
Peptideexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 7, 2019 (NCT05567393)
Timeline
Indications
Mechanism of action
- Serotonin 4 (5-HT4) receptorAGONIST
HTR4 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06768658 | Phase 1 | Mar 2, 2022 | Takeda |
| NCT06610279 | Phase 1 | Jan 7, 2022 | Takeda |
| NCT04557189 | Phase 2 | Oct 20, 2020 | Takeda |
| NCT04486950 | Phase 1 | Jul 7, 2020 | Takeda |
| NCT05567393 | Phase 1 | Mar 7, 2019 | Takeda |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Takeda | For profit | 5 | 5 | 2 | 2019 |
1 organizations
Page 1 / 1